Login / Signup

Design, synthesis and mechanistic study of new dual targeting HDAC/tubulin inhibitors.

Mona S El-ZoghbiAmr Ka BassGamal El-Din A Abuo-RahmaMamdouh F A MohamedMohamed BadrHanan A Al-GhulikahEl Shimaa M N Abdelhafez
Published in: Future medicinal chemistry (2024)
Aim: The purpose of this work is to create and synthesize a new class of chemicals: 3-cyano-2-substituted pyridine compounds with expected multitarget inhibition of histone deacetylase (HDAC) and tubulin. Materials & methods: The target compounds ( 3a-c, 4a-c and 5a-c ) were synthesized utilizing 6-(4-methoxyphenyl)-2-oxo-4-(3,4,5-trimethoxyphenyl)-3-cyanopyridine, with various linkers and zinc-binding groups (ZBGs). Results: Most of the tested compounds showed promising growth inhibition, and hydroxamic acid-containing hybrids possessed higher HDAC inhibition than other ZBGs. Compound 4b possessed the highest potency; however, it showed the most tubulin polymerization inhibition. Docking studies displayed good binding into HDAC1 and six pockets and tubulin polymerization protein. Conclusion: Compound 4b could be considered a good antitumor candidate to go further into in vivo and clinical studies.
Keyphrases
  • histone deacetylase
  • protein protein
  • molecular dynamics
  • small molecule
  • molecular dynamics simulations
  • dna binding
  • cancer therapy
  • amino acid
  • case control